Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Anne Tosto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|April 23, 2019
Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndromeAsaf Shilo, Frances Anne Tosto, Jason W Rausch, et al.
Journal of Medicinal Chemistry|August 6, 2025
Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative MedicinePatrick J Morris, Damien Y Duveau, Michele Ceribelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2022
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305Krista Kinneer, Philipp Wortmann, Zachary A Cooper, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|April 23, 2019
Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndromeAsaf Shilo, Frances Anne Tosto, Jason W Rausch, et al.
Journal of Medicinal Chemistry|August 6, 2025
Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative MedicinePatrick J Morris, Damien Y Duveau, Michele Ceribelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2022
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305Krista Kinneer, Philipp Wortmann, Zachary A Cooper, et al.
Pageof 1